- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Ansis Helmanis
Articles
ISPOR Task Force Grapples with Value Questions
ISPOR's Value Assessment Stakeholder Conference showed its Special Task Force still reaching for clarification around the subject, writes Ansis Helmanis.
Pharmaceutical Executive
IP: Securing a Global Consensus—Can Industry Do It Again?
Harvey Bale, Jr., MD, former Director-General, IFPMA
Pharmaceutical Executive
Jane Henney: Lessons from the FDA Front Line
Jane Henney, MD, Former FDA Commissioner